Relationship between OprD porin downregulation and in-vitro interactions in Pseudomonas aeruginosa

Tuba Müderris1, Ufuk Akbayırlı2, Rıza Durmaz3

  • 1İzmir Katip Çelebi University, Faculty of Medicine, Department of Medical Microbiology, İzmir, Türkiye.

Abstract

Insights

OprD porin downregulation significantly enhances meropenem/colistin synergy in Pseudomonas aeruginosa. Other combinations showed limited synergy, indicating OprD

Area of Science:

  • Microbiology
  • Pharmacology
  • Infectious Diseases

Background:

  • OprD porin is crucial for antibiotic entry into Pseudomonas aeruginosa.
  • The precise role of OprD in antimicrobial interactions remains incompletely understood.
  • This study examines OprD downregulation's impact on meropenem combinations.

Purpose of the Study:

  • To investigate the relationship between OprD downregulation and in vitro interactions of meropenem (MEM).
  • To evaluate MEM combined with colistin (CT), ertapenem (ETP), and fosfomycin (FF) against P. aeruginosa isolates with varying OprD expression.
  • To determine the synergistic effects of these combinations in OprD-suppressed versus non-suppressed isolates.

Main Methods:

  • Utilized 40 Pseudomonas aeruginosa isolates, divided into two groups based on OprD suppression (n=20 each).
  • Employed the checkerboard method to assess antimicrobial interactions in vitro.
  • Quantified synergy rates and changes in minimum inhibitory concentrations (MICs) for drug combinations.

Main Results:

  • Meropenem/colistin (MEM/CT) exhibited higher synergy rates in OprD-suppressed isolates (45%) compared to non-suppressed (30%).
  • Significant decreases in MICs were observed for MEM and CT in the MEM/CT combination for OprD-suppressed isolates.
  • Meropenem/ertapenem (MEM/ETP) and meropenem/fosfomycin (MEM/FF) showed limited synergy across both groups.

Conclusions:

  • OprD downregulation significantly enhances the synergistic effect of meropenem/colistin against P. aeruginosa.
  • The impact of OprD on antimicrobial resistance is complex and combination-dependent.
  • Colistin combined with meropenem shows potential to overcome OprD-mediated resistance mechanisms; further in vivo validation is recommended.